4.3 Article

High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a Long-term follow-up study

Related references

Note: Only part of the references are listed.
Article Rheumatology

Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study- results at 5 years of follow-up

Maria A. Martin-Martinez et al.

Summary: The study found that patients with chronic inflammatory rheumatic diseases have a lower cardiovascular mortality rate after 5 years of follow-up. PsA patients had the highest incidence rate of the first CVE at 5 years. However, after adjusting for age, sex, and cardiovascular risk factors, AS patients were more commonly associated with CVE compared to those without CIRD.

RHEUMATOLOGY (2021)

Article Rheumatology

Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis

Steven H. Lam et al.

Summary: Elevated CRP levels in PsA patients were associated with an increased risk of cardiovascular events, while the risk was significantly reduced with the use of NSAIDs.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

Article Rheumatology

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs

Shirley Chiu Wai Chan et al.

Summary: The study found that patients with spondyloarthritis (SpA) have a higher risk of cardiovascular diseases, with hypercholesterolemia being more common. The use of anti-tumor necrosis factor (TNF) drugs is associated with a reduced cardiovascular risk in patients with SpA.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

Article Rheumatology

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study

Steven Ho Man Lam et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Letter Rheumatology

Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis

Sylvain Mathieu et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Review Peripheral Vascular Disease

Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis

Yaping Yuan et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)

Article Rheumatology

Mortality in ankylosing spondylitis: results from a nationwide population-based study

Sofia Exarchou et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Review Cardiac & Cardiovascular Systems

A Test in Context High-Sensitivity C-Reactive Protein

Paul M. Ridker

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Medicine, General & Internal

Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study

Nisha Nigil Haroon et al.

ANNALS OF INTERNAL MEDICINE (2015)

Article Rheumatology

Increased mortality in ankylosing spondylitis is related to disease activity

Gunnstein Bakland et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Article Medicine, General & Internal

Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007

Maria Chiu et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

General cardiovascular risk profile for use in primary care - The Framingham Heart Study

Ralph B. D'Agostino et al.

CIRCULATION (2008)

Article Cardiac & Cardiovascular Systems

Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project

RM Conroy et al.

EUROPEAN HEART JOURNAL (2003)

Article Medicine, General & Internal

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

PM Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)